LATEST ALERTS
An original and potentially highly significant piece of peer-reviewed research published last week could – and should – have an impact on the way e-cigarettes are regarded and regulated in the US
Breeze Smoke is asking the US Supreme Court to stay a Food and Drug Administration (FDA) marketing denial order (MDO) after the Court of Appeals rejected such motion
Robert Califf, US president Joe Biden’s choice to take up leadership of the FDA again, has unfinished business with the agency – and with e-cigarettes in particular
A 70-year-old cardiologist who has backed a flavour ban on vaping products has been nominated by president Joe Biden to return to the role of commissioner of the US Food and Drug Administration (FDA)
A US court has granted another stay request to a company that sued the US Food and Drug Administration (FDA) after the agency issued a marketing denial order (MDO) for its flavoured vaping products
This report answers your questions on the US Food and Drug Administration (FDA)’s recently issued final rules on the requirements for Premarket Tobacco Product Applications (PMTAs) and Substantial Equivalence (SE) reports
Florida-based e-cigarette manufacturer Bidi Vapor has taken the US FDA to court claiming “continued irreparable harm” from being given a marketing denial order (MDO) for its vaping products
The US Court of Appeals for the Fifth Circuit concluded that the FDA “inadequately addressed or explained” a PMTA that resulted in a MDO, and decided to temporary allow a company from Texas to keep its flavoured products on the market until it resolves the case
While some of the biggest players in the US vapour market wait for the Food and Drug Administration (FDA) to decide whether their products can remain on sale, the agency has provided some insight into its processes and priorities
“The importance of the FDA authorising a vaping product as ‘appropriate for the protection of public health’ should not be understated,” said Greg Conley, president of the American Vaping Association
The granting of RJ Reynolds’s PMTAs for its Vuse Solo e-cigarette device and two of its pods is very big news for the US vaping industry, its supporters, its customers, and its opponents
The US Food and Drug Administration (FDA) has issued its first marketing authorisations for e-cigarette products, following the rejection of millions of others. The authorisations cover RJ Reynolds’s Vuse Solo device and two 4.8% nicotine tobacco-flavoured pods
The US Food and Drug Administration (FDA) has rescinded its marketing denial order (MDO) affecting 14 Turning Point Brands products, saying “relevant information that was not adequately assessed”
Turning Point Brands (TPB) is challenging in court the Marketing Denial Order (MDO) issued by the US Food and Drug Administration (FDA) to its premarket tobacco product applications (PMTAs) as it considers the decision “arbitrary”
A presentation given by Tim Phillips, ECigIntelligence managing director, to the ENDS US Workshop in October 2021
Some light is now dawning on some truths long since suspected about the US Food and Drug Administration (FDA)’s evaluation of e-cigarettes
US senators have urged the FDA to implement a timeline to decide on the pending PMTAs and to reveal how it will ensure that there are no non-compliant products on the market
Representatives of the vaping industry have urged a broader collaboration with scientists and agreed that integrating technological innovations is key to encouraging transition to tobacco alternatives
The US FDA’s rejection of premarket tobacco product applications (PMTAs) has sown confusion among vape retailers, who are urging the agency to make public which vaping products have been approved for sale
The dog didn’t eat all the FDA’s homework – just 7% of it. But there will be those who argue that the missing 7% was the crucial bit all along
The US Food and Drug Administration (FDA)’s denial of premarket tobacco product applications (PMTAs) has been welcomed by politicians and public health bodies – with severe reservations about the delay over Juul and others
The US Food and Drug Administration (FDA) has rejected most of the 6m premarket tobacco product applications (PMTAs) it received for vaping products, but Juul’s intently-watched application remains under review
As the US Food and Drug Administration’s deadline to pass or reject e-cigarette premarket tobacco product applications (PMTAs) arrives, where does it leave the market and the as-yet undetermined applications?
The US Food and Drug Administration (FDA) has issued a number of “additional” marketing denial orders (MDOs) for flavoured e-cigarettes, denying their premarket tobacco product applications (PMTAs)
It’s hard to argue against the view that packaging and advertising e-cigarette products in a “kid-friendly” way is irresponsible. But are flavours in themselves innately kid-friendly?
Both the House and the Senate are intent on increasing the US Food and Drug Administration (FDA) budget for next year, but the figure is likely to be well short of the $6.5bn proposed by president Joe Biden
31 US state attorneys want to ban all non-tobacco flavours, including menthol, from e-cigarettes – but is their plea helpful, appropriate or logical?
The US Food and Drug Administration (FDA) has ruled out premarket tobacco product applications (PMTAs) for 55,000 flavoured vapour products after concluding that on balance they pose a threat to public health
A group of 31 US attorneys general has joined together in urging the Food and Drug Administration (FDA) to deny premarket tobacco product applications (PMTAs) for vaping products
The number of applications thrown in the metaphorical dumpster is huge, but so is number of outstanding applications, and the question remains how the FDA can possibly deal with all of them
A bipartisan group of federal senators have reintroduced a bill in Congress that would force e-cigarette manufacturers to pay user fees to the FDA in a bid to fund the federal agency
After the recent announcement that FDA rejected 4.5m of the total 6m PMTAs filed, experts believe that this decision is a clear path for enforcement
A small manufacturer from Texas must remove millions of vaping products from the US market after the FDA issued a Refuse to File (RTF) letter rejecting most of its PMTAs
Five US companies are top of the list with the most PMTAs submitted, and represent five out of the 6m total applications by the September 2020 deadline
An analysis of the long-awaited list of PMTA applications that was recently published by the US Food and Drug Administration
An analysis of the long-awaited list of PMTA applications that was recently published by the US Food and Drug Administration
The US press are calling it a “fight for survival” for the e-cigarette giant – but as one experts says, “The FDA has to evaluate this in a forward-looking way and can’t really punish Juul”
E-cigarettes manufactured by large companies may soon dominate the US vape market while many of those produced by smaller players disappear, new research by ECigIntelligence suggests
What do the 6m-plus premarket tobacco product applications (PMTAs) received by the US Food and Drug Administration (FDA) reveal about the current state of the US e-cigarette industry? We assess the FDA data
The US Food and Drug Administration (FDA)’s authority to regulate e-cigarettes could face further legal scrutiny after the recent refusal by the Supreme Court to hear a challenge initiated by a vape shop
It was always a long shot – such a long shot that no one, surely, was surprised that the US Supreme Court refused to review the case
The US Supreme Court has rejected a challenge to the Food and Drug Administration (FDA)’s authority to regulate e-cigarettes, refusing to review a case that relied on a constitutional doctrine last applied in 1935
The US Food and Drug Administration (FDA) has posted a list of over 6m deemed new tobacco products for which it received Premarket Tobacco Product Applications (PMTAs) by the 9th September 2020 deadline
News that the Biden administration is considering reducing nicotine levels in combustible cigarettes in the US has affected stock prices in the UK – and has potentially interesting implications for the vaping market
New research suggests “exposure to e-cigarette product placement in music videos is associated with vaping among young adults”. Meanwhile, back in the Marvel universe, something strange is stirring
A group of eight vaping companies are escalating their legal fight against the US Food and Drug Administration (FDA)’s oversight of e-cigarette products, and in particular the premarket approval (PMTA) process
A group of 40 House Democrats have written to the US Food and Drug Administration (FDA) pressing it to remove from the market all flavoured e-cigarettes “fueling youth tobacco epidemic” and to make an example of Juul
This special report details the e-cigarette flavour bans or restrictions in place in four US states, and analyses those under consideration at state level elsewhere across the nation
Vaping companies across the US are under pressure, with some going out of business and others saying they face a struggle to survive, as the Food and Drug Administration (FDA) tightens the regulatory screw
Will a new political era in the US mean a new regulatory landscape for e-cigarettes?
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields
